Cargando…
Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole
Objective: The aim of this study was to investigate the effects of a potent CYP3A4 inducer, rifampicin (Study A), and a potent CYP3A4 inhibitor, itraconazole (Study B), on the pharmacokinetics of a single 300mg dose of vandetanib in healthy subjects. Study Design and Setting: Two phase I, randomized...
Autores principales: | Martin, Paul, Oliver, Stuart, Robertson, Jane, Kennedy, Sarah-Jane, Read, Jessica, Duvauchelle, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586143/ https://www.ncbi.nlm.nih.gov/pubmed/21410294 http://dx.doi.org/10.2165/11586980-000000000-00000 |
Ejemplares similares
-
Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies
por: Hashimoto, Satsuki, et al.
Publicado: (2018) -
Evaluation of the Pharmacokinetic Drug Interaction of Capmatinib With Itraconazole and Rifampicin and Potential Impact on Renal Transporters in Healthy Subjects
por: Cui, Xiaoming, et al.
Publicado: (2022) -
Clinical evaluation of the potential drug–drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolam
por: Ren, Song, et al.
Publicado: (2021) -
Vandetanib
por: Vozniak, J. Michael, et al.
Publicado: (2012) -
Effects of itraconazole and rifampicin on the single‐dose pharmacokinetics of the nonsteroidal mineralocorticoid receptor blocker esaxerenone in healthy Japanese subjects
por: Kirigaya, Yoshiaki, et al.
Publicado: (2020)